在乌干达和肯尼亚农村地区的产前和产后护理诊所开展动态选择预防艾滋病随机试验》(Randomized Trial of Dynamic Choice HIV Prevention at Antenatal and Postatal Care Clinics in Rural Uganda and Kenya)。

IF 2.9 3区 医学 Q3 IMMUNOLOGY
Jane Kabami, Catherine A Koss, Helen Sunday, Edith Biira, Marilyn Nyabuti, Laura B Balzer, Shalika Gupta, Gabriel Chamie, James Ayieko, Elijah Kakande, Melanie C Bacon, Diane Havlir, Moses R Kamya, Maya Petersen
{"title":"在乌干达和肯尼亚农村地区的产前和产后护理诊所开展动态选择预防艾滋病随机试验》(Randomized Trial of Dynamic Choice HIV Prevention at Antenatal and Postatal Care Clinics in Rural Uganda and Kenya)。","authors":"Jane Kabami, Catherine A Koss, Helen Sunday, Edith Biira, Marilyn Nyabuti, Laura B Balzer, Shalika Gupta, Gabriel Chamie, James Ayieko, Elijah Kakande, Melanie C Bacon, Diane Havlir, Moses R Kamya, Maya Petersen","doi":"10.1097/QAI.0000000000003383","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pregnant and postpartum women in Sub-Saharan Africa are at high risk of HIV acquisition. We evaluated a person-centered dynamic choice intervention for HIV prevention (DCP) among women attending antenatal and postnatal care.</p><p><strong>Setting: </strong>Rural Kenya and Uganda.</p><p><strong>Methods: </strong>Women (aged 15 years or older) at risk of HIV acquisition seen at antenatal and postnatal care clinics were individually randomized to DCP vs. standard of care (SEARCH; NCT04810650). The DCP intervention included structured client choice of product (daily oral pre-exposure prophylaxis or postexposure prophylaxis), service location (clinic or out of facility), and HIV testing modality (self-test or provider-administered), with option to switch over time and person-centered care (phone access to clinician, structured barrier assessment and counseling, and provider training). The primary outcome was biomedical prevention coverage-proportion of 48-week follow-up with self-reported pre-exposure prophylaxis or postexposure prophylaxis use, compared between arms using targeted maximum likelihood estimation.</p><p><strong>Results: </strong>Between April and July 2021, we enrolled 400 women (203 intervention and 197 control); 38% were pregnant, 52% were aged 15-24 years, and 94% reported no pre-exposure prophylaxis or postexposure prophylaxis use for ≥6 months before baseline. Among 384/400 participants (96%) with outcome ascertained, DCP increased biomedical prevention coverage 40% (95% CI: 34% to 47%; P < 0.001); the coverage was 70% in intervention vs. 29% in control. DCP also increased coverage during months at risk of HIV (81% in intervention, 43% in control; 38% absolute increase; 95% CI: 31% to 45%; P < 0.001).</p><p><strong>Conclusion: </strong>A person-centered dynamic choice intervention that provided flexibility in product, testing, and service location more than doubled biomedical HIV prevention coverage in a high-risk population already routinely offered access to biomedical prevention options.</p>","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":"95 5","pages":"447-455"},"PeriodicalIF":2.9000,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10927304/pdf/","citationCount":"0","resultStr":"{\"title\":\"Randomized Trial of Dynamic Choice HIV Prevention at Antenatal and Postnatal Care Clinics in Rural Uganda and Kenya.\",\"authors\":\"Jane Kabami, Catherine A Koss, Helen Sunday, Edith Biira, Marilyn Nyabuti, Laura B Balzer, Shalika Gupta, Gabriel Chamie, James Ayieko, Elijah Kakande, Melanie C Bacon, Diane Havlir, Moses R Kamya, Maya Petersen\",\"doi\":\"10.1097/QAI.0000000000003383\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Pregnant and postpartum women in Sub-Saharan Africa are at high risk of HIV acquisition. We evaluated a person-centered dynamic choice intervention for HIV prevention (DCP) among women attending antenatal and postnatal care.</p><p><strong>Setting: </strong>Rural Kenya and Uganda.</p><p><strong>Methods: </strong>Women (aged 15 years or older) at risk of HIV acquisition seen at antenatal and postnatal care clinics were individually randomized to DCP vs. standard of care (SEARCH; NCT04810650). The DCP intervention included structured client choice of product (daily oral pre-exposure prophylaxis or postexposure prophylaxis), service location (clinic or out of facility), and HIV testing modality (self-test or provider-administered), with option to switch over time and person-centered care (phone access to clinician, structured barrier assessment and counseling, and provider training). The primary outcome was biomedical prevention coverage-proportion of 48-week follow-up with self-reported pre-exposure prophylaxis or postexposure prophylaxis use, compared between arms using targeted maximum likelihood estimation.</p><p><strong>Results: </strong>Between April and July 2021, we enrolled 400 women (203 intervention and 197 control); 38% were pregnant, 52% were aged 15-24 years, and 94% reported no pre-exposure prophylaxis or postexposure prophylaxis use for ≥6 months before baseline. Among 384/400 participants (96%) with outcome ascertained, DCP increased biomedical prevention coverage 40% (95% CI: 34% to 47%; P < 0.001); the coverage was 70% in intervention vs. 29% in control. DCP also increased coverage during months at risk of HIV (81% in intervention, 43% in control; 38% absolute increase; 95% CI: 31% to 45%; P < 0.001).</p><p><strong>Conclusion: </strong>A person-centered dynamic choice intervention that provided flexibility in product, testing, and service location more than doubled biomedical HIV prevention coverage in a high-risk population already routinely offered access to biomedical prevention options.</p>\",\"PeriodicalId\":14588,\"journal\":{\"name\":\"JAIDS Journal of Acquired Immune Deficiency Syndromes\",\"volume\":\"95 5\",\"pages\":\"447-455\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10927304/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAIDS Journal of Acquired Immune Deficiency Syndromes\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/QAI.0000000000003383\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/11 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003383","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/11 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:撒哈拉以南非洲地区的孕妇和产后妇女是艾滋病病毒感染的高危人群。我们在接受产前和产后护理的妇女中评估了一种以人为本的预防艾滋病动态选择干预措施(DCP):环境:肯尼亚和乌干达农村地区:在产前和产后护理诊所就诊的有感染艾滋病风险的妇女(15 岁或以上)被单独随机分配到 DCP 与标准护理(SEARCH;NCT04810650)。DCP 干预措施包括让客户有条理地选择产品(每日口服暴露前预防或暴露后预防)、服务地点(诊所或设施外)和 HIV 检测方式(自我检测或服务提供者管理),并可在一段时间后进行转换,以及以人为本的护理(电话联系临床医生、有条理的障碍评估和咨询以及服务提供者培训)。主要结果是生物医学预防覆盖率--48周随访中自我报告暴露前预防或暴露后预防的比例,采用有针对性的最大似然估计法对不同方案进行比较:2021 年 4 月至 7 月间,我们招募了 400 名妇女(干预组 203 人,对照组 197 人);其中 38% 为孕妇,52% 年龄在 15-24 岁之间,94% 报告在基线前≥6 个月内未使用过暴露前预防或暴露后预防。在已确定结果的 384/400 名参与者(96%)中,DCP 将生物医学预防覆盖率提高了 40% (95% CI: 34% to 47%; P < 0.001);干预组的覆盖率为 70%,对照组为 29%。DCP 还提高了在 HIV 高危月份的覆盖率(干预组为 81%,对照组为 43%;绝对增幅为 38%;95% CI:31% 至 45%;P <0.001):以人为本的动态选择干预措施在产品、检测和服务地点方面提供了灵活性,在高危人群中,生物医学预防艾滋病的覆盖率增加了一倍多,而这些人群已经能够定期获得生物医学预防选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Randomized Trial of Dynamic Choice HIV Prevention at Antenatal and Postnatal Care Clinics in Rural Uganda and Kenya.

Background: Pregnant and postpartum women in Sub-Saharan Africa are at high risk of HIV acquisition. We evaluated a person-centered dynamic choice intervention for HIV prevention (DCP) among women attending antenatal and postnatal care.

Setting: Rural Kenya and Uganda.

Methods: Women (aged 15 years or older) at risk of HIV acquisition seen at antenatal and postnatal care clinics were individually randomized to DCP vs. standard of care (SEARCH; NCT04810650). The DCP intervention included structured client choice of product (daily oral pre-exposure prophylaxis or postexposure prophylaxis), service location (clinic or out of facility), and HIV testing modality (self-test or provider-administered), with option to switch over time and person-centered care (phone access to clinician, structured barrier assessment and counseling, and provider training). The primary outcome was biomedical prevention coverage-proportion of 48-week follow-up with self-reported pre-exposure prophylaxis or postexposure prophylaxis use, compared between arms using targeted maximum likelihood estimation.

Results: Between April and July 2021, we enrolled 400 women (203 intervention and 197 control); 38% were pregnant, 52% were aged 15-24 years, and 94% reported no pre-exposure prophylaxis or postexposure prophylaxis use for ≥6 months before baseline. Among 384/400 participants (96%) with outcome ascertained, DCP increased biomedical prevention coverage 40% (95% CI: 34% to 47%; P < 0.001); the coverage was 70% in intervention vs. 29% in control. DCP also increased coverage during months at risk of HIV (81% in intervention, 43% in control; 38% absolute increase; 95% CI: 31% to 45%; P < 0.001).

Conclusion: A person-centered dynamic choice intervention that provided flexibility in product, testing, and service location more than doubled biomedical HIV prevention coverage in a high-risk population already routinely offered access to biomedical prevention options.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.80
自引率
5.60%
发文量
490
审稿时长
3-6 weeks
期刊介绍: JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信